Relief Therapeutics Holding AG (RLFTF)

[go_wamu]

In this study:

A Multicenter, Adaptive, Randomized, Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for Hospitalized Patients With Acute Respiratory Distress Syndrome Associated With COVID-19

"Zyesami" is not mentioned in a single word. There is ever mentioned Aviptadil only.
Administrative Information: Studies a U.S. FDA-regulated drug product: Yes (AVIPTADIL !)
Collaborators including: NeuroRX (where is Relief Therapeutics?)
Start of the study: April 20, 2021
Estimated Primary Completion Date: October 2022
Estimated Study Completion Date: April 2023
What drug is realy used during trial ? (ZYESAMI ?)

Is nobody able to see a Christmas tree being cleared here?
Think about it !